Neoplasm
Information
- Disease name
- Neoplasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02851706 | Active, not recruiting | Natural History of and Specimen Banking for People With Tumors of the Central Nervous System | September 1, 2016 | April 5, 2100 | |
| NCT00001336 | Completed | In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients | April 1993 | February 2003 | |
| NCT00001341 | Completed | Phase 1 | A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease | September 1993 | June 2001 |
| NCT00001444 | Completed | Phase 1 | A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | August 1995 | May 2002 |
| NCT00001500 | Completed | Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits | April 1996 | July 2004 | |
| NCT00001572 | Completed | Phase 1 | Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | January 30, 1997 | November 2, 2010 |
| NCT00001580 | Completed | Tissue Acquisition for Molecular Diagnostics | June 1997 | March 2003 | |
| NCT00001695 | Completed | Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials | April 1998 | January 2002 | |
| NCT00001835 | Completed | Phase 1 | Oxaliplatin in Cancer Patients With Impaired Kidney Function | September 1999 | December 2001 |
| NCT00004988 | Completed | Phase 1 | Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria | March 2000 | October 2002 |
| NCT00026858 | Completed | Phase 2 | Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts | October 1994 | November 2002 |
| NCT00026871 | Completed | Phase 1 | Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System | July 1997 | May 2006 |
| NCT00026897 | Completed | Phase 2 | Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer | December 1997 | December 2002 |
| NCT00026936 | Completed | Phase 2 | A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning | May 1999 | January 2005 |
| NCT00028249 | Completed | Process and Outcomes of Pain Management | December 2001 | December 2005 | |
| NCT00034879 | Completed | Phase 3 | Iressa Expanded Access Program (EAP) | August 2000 | October 2003 |
| NCT00062491 | Completed | Phase 2 | Study of Karenitecin (BNP1350) to Treat Malignant Melanoma | May 2002 | November 2005 |
| NCT00080418 | Completed | Phase 1 | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer | July 2003 | June 2010 |
| NCT00083720 | Completed | Phase 2 | Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy | October 2004 | April 2008 |
| NCT00100139 | Completed | Phase 1 | Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer | November 2004 | June 2010 |
| NCT00105599 | Completed | Phase 2 | Effectiveness of the FairCare System for Patients With Advanced Illness | September 2004 | |
| NCT00143533 | Completed | Phase 1 | Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors | September 2003 | June 2011 |
| NCT00199836 | Completed | Phase 1 | A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. | September 3, 2003 | June 6, 2006 |
| NCT00226005 | Completed | Phase 2 | PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma | December 2005 | February 2010 |
| NCT00270127 | Completed | Phase 3 | Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | August 1996 | September 1998 |
| NCT00270166 | Completed | Phase 3 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | February 1995 | May 1998 |
| NCT00283465 | Completed | Phase 4 | A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy | November 1999 | April 2004 |
| NCT00001150 | Completed | Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers | October 1976 | March 2004 | |
| NCT01269645 | Completed | N/A | Facts and Attitudes About Clinical Trials | July 2009 | July 2014 |
| NCT01395407 | Completed | Phase 1 | Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases | July 2011 | October 2015 |
| NCT01425008 | Completed | Phase 1 | Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma | September 15, 2011 | October 16, 2018 |
| NCT01457196 | Completed | N/A | Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions | September 2011 | June 6, 2018 |
| NCT01517464 | Completed | Phase 1 | A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors | January 2012 | December 2015 |
| NCT01672944 | Completed | N/A | Evaluating Biobanking Educational Tools | September 27, 2010 | September 17, 2021 |
| NCT01708850 | Completed | Phase 4 | Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) | November 2012 | June 2016 |
| NCT01794104 | Completed | Phase 1 | Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas | February 15, 2013 | October 27, 2017 |
| NCT01920061 | Completed | Phase 1 | A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) | September 10, 2013 | January 8, 2020 |
| NCT01942005 | Completed | EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients | January 2010 | May 2014 | |
| NCT01962103 | Completed | Phase 1/Phase 2 | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors | December 4, 2013 | November 6, 2018 |
| NCT02044536 | Completed | Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy | January 2014 | January 2014 | |
| NCT02117648 | Completed | Phase 1 | A Study of LY2835219 in Participants With Cancer | April 2014 | August 2015 |
| NCT02215733 | Completed | The Use of Angiotensin Receptor Blockers and the Risk of Cancer | February 2011 | ||
| NCT02304419 | Completed | Phase 1 | A Study of Galunisertib on the Immune System in Participants With Cancer | May 2015 | August 2016 |
| NCT02309164 | Completed | N/A | The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). | September 2014 | November 2015 |
| NCT02377752 | Completed | Phase 1 | A Study of Olaratumab in Japanese Participants With Advanced Cancer | March 23, 2015 | January 14, 2020 |
| NCT02394821 | Completed | Phase 3 | Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide | September 2013 | September 2015 |
| NCT02514603 | Completed | Phase 1 | A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers | October 2015 | April 10, 2017 |
| NCT02536586 | Completed | Phase 1 | A Study of LY3023414 in Japanese Participants With Advanced Cancer | September 2015 | February 9, 2017 |
| NCT02684266 | Completed | Phase 1 | A Study of SHR6390 in Advanced Solid Tumor Patients | March 3, 2016 | June 28, 2019 |
| NCT02699606 | Completed | Phase 2 | A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma | July 8, 2016 | March 15, 2024 |
| NCT02743637 | Completed | Phase 1 | A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors | February 2016 | December 16, 2019 |
| NCT02746185 | Completed | Phase 3 | Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban | September 2016 | April 25, 2018 |
| NCT02747342 | Completed | Phase 1 | A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer | September 2016 | June 28, 2020 |
| NCT02759640 | Completed | Phase 1 | A Phase I Trial of HS-10241 in Solid Tumors | September 2016 | May 2018 |
| NCT02759666 | Completed | Phase 1 | A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors | June 1, 2016 | April 26, 2019 |
| NCT02875327 | Completed | Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data | August 5, 2016 | May 20, 2020 | |
| NCT03415126 | Completed | Phase 1 | A Study of ASN007 in Patients With Advanced Solid Tumors | January 19, 2018 | June 30, 2020 |
| NCT03547037 | Completed | Phase 1 | A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers | August 31, 2018 | July 4, 2022 |
| NCT04138823 | Completed | Phase 1 | A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) | November 26, 2019 | May 17, 2023 |
| NCT04142567 | Completed | Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation | February 11, 2020 | October 22, 2021 | |
| NCT04280159 | Completed | Modern Hybrid Imaging in Patients With OSCC | June 28, 2013 | December 31, 2018 | |
| NCT00407498 | Completed | Phase 1 | Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms | May 2005 | September 2008 |
| NCT00408434 | Completed | Phase 1 | Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer | November 2006 | February 2010 |
| NCT00448344 | Completed | N/A | Family-supported Smoking Cessation for Chronically Ill Veterans | February 2008 | July 2012 |
| NCT00470613 | Completed | Phase 1 | Safety Study of Infusion of SGT-53 to Treat Solid Tumors | February 2008 | December 2016 |
| NCT00496353 | Completed | Phase 1/Phase 2 | MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) | June 2007 | November 2008 |
| NCT00520299 | Completed | Phase 1/Phase 2 | Study of ADI-PEG 20 in Patients With Advanced Melanoma | July 2007 | March 2010 |
| NCT00573872 | Completed | N/A | A Phase II Study of Spinal Radiosurgery | April 2005 | September 2016 |
| NCT00657254 | Completed | Phase 2 | Extension Program for Bay 43-9006 | December 2002 | June 2005 |
| NCT00692159 | Completed | Phase 1 | Study of TRC102 in Combination With Pemetrexed in Cancer Patients | June 2008 | September 2010 |
| NCT00694083 | Completed | Phase 1 | Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED) | June 10, 2008 | September 6, 2009 |
| NCT00694356 | Completed | Phase 1 | Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009) | August 4, 2008 | April 28, 2009 |
| NCT00936104 | Completed | Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) | August 2008 | July 2012 | |
| NCT00961831 | Completed | Phase 1 | Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients | April 15, 2009 | December 16, 2009 |
| NCT00988195 | Completed | Phase 1 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | May 2008 | August 2009 |
| NCT01092091 | Completed | Phase 1/Phase 2 | Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) | March 2010 | February 2012 |
| NCT01104077 | Completed | Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) | November 17, 2008 | April 27, 2021 | |
| NCT01105533 | Completed | Phase 1 | A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors | May 2006 | September 2011 |
| NCT01117623 | Completed | Phase 1 | Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies | February 2007 | November 2013 |
| NCT01155713 | Completed | Phase 1 | Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors | July 2010 | November 2013 |
| NCT01163110 | Completed | Phase 1 | Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy | March 2004 | June 2007 |
| NCT02154022 | Enrolling by invitation | Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity | July 31, 2014 | May 1, 2030 | |
| NCT02955446 | No longer available | Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies | |||
| NCT02473497 | No longer available | Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients | |||
| NCT00695279 | Recruiting | Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products | January 4, 2007 | December 2036 | |
| NCT05101798 | Recruiting | Phase 2 | The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial | September 14, 2021 | March 2025 |
| NCT02925234 | Recruiting | Phase 2 | The Drug Rediscovery Protocol (DRUP Trial) | August 2016 | December 2027 |
| NCT04717375 | Recruiting | Phase 1/Phase 2 | Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors | April 11, 2021 | February 24, 2027 |
| NCT05450562 | Recruiting | Phase 1/Phase 2 | Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors | September 20, 2022 | December 12, 2030 |
| NCT05909202 | Recruiting | N/A | A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients | June 5, 2024 | September 1, 2029 |
| NCT02354547 | Suspended | Phase 1 | A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors | December 2014 | December 2023 |
| NCT03099161 | Terminated | Phase 1 | Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) | June 27, 2017 | February 21, 2018 |
| NCT03251924 | Terminated | Phase 1/Phase 2 | A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors | September 1, 2017 | December 20, 2021 |
| NCT00408018 | Terminated | Phase 1 | Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms | March 2006 | October 2008 |
| NCT05013554 | Terminated | Phase 1 | Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors | August 16, 2021 | January 15, 2024 |
| NCT00505414 | Terminated | Phase 3 | A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine | June 2007 | May 2009 |
| NCT03637764 | Terminated | Phase 1/Phase 2 | Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies | August 6, 2018 | May 11, 2022 |
| NCT05429762 | Terminated | Phase 1 | Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors | October 3, 2022 | April 10, 2024 |
| NCT00023166 | Terminated | Phase 1 | Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas | May 2001 | May 2002 |
| NCT01104116 | Terminated | N/A | Use of PET Imaging to Distinguish Malignant From Benign IPMN | September 2009 | March 2016 |
| NCT02434146 | Terminated | Phase 1/Phase 2 | Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy | May 14, 2015 | January 25, 2017 |
| NCT02440685 | Terminated | Phase 1/Phase 2 | A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | May 2015 | July 2018 |
| NCT01287013 | Terminated | N/A | Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures | January 2011 | August 2015 |
| NCT01441115 | Terminated | Phase 1 | ECI301 and Radiation for Advanced or Metastatic Cancer | September 6, 2011 | April 24, 2013 |
| NCT00321958 | Terminated | Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer | April 2006 | May 2007 | |
| NCT01863303 | Unknown status | Epidemiological Study of Colorectal Cancer in WuHan | June 2012 | June 2018 | |
| NCT01287286 | Unknown status | Phase 2/Phase 3 | Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy | June 2010 | May 2012 |
| NCT02828449 | Unknown status | N/A | Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy | November 2016 | March 2018 |
| NCT02226289 | Unknown status | Phase 2 | Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment | September 2020 | December 2020 |
| NCT02450175 | Unknown status | N/A | Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls | June 2014 | June 2016 |
| NCT00747292 | Unknown status | Phase 1/Phase 2 | Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery | December 2007 | October 2009 |
| NCT01693172 | Unknown status | N/A | Effect of an Early Mobilization Program on Outcomes After Major Cancer Surgery | December 2014 | January 2016 |
| NCT04203524 | Unknown status | N/A | Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients With Sepsis | August 21, 2019 | September 21, 2023 |
| NCT02578667 | Withdrawn | N/A | Gorbly Compression Device for Use in Image-guided Procedures | December 2015 | January 2016 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0003008
- HPO alt_id (Human Phenotype Ontology)
- HP:0006741
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002664